share_log
Reuters ·  Jul 12 10:00
FDA Grants Fast Track Designation to 9MW2821 for the Treatment of Patients With Locally Advanced or Metastatic Nectin-4 Positive Tnbc
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment